Желудочные войны

www.vyalov.com

Использованная литература

Часть 1. Борьба за желудок

1. Thrift AP. Determination of risk for Barrett’s esophagus and esophageal adenocarcinoma. Curr Opin Gastroenterol. 2016

2. Zhao Z, Pu Z, Yin Z, et al. Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett’s esophagus risk: a systematic review and meta-analysis. Sci Rep. 2016

3. Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016

4. Salvador R, Dubecz A, Polomsky M, et al. A new era in esophageal diagnostics: the image-based paradigm of high-resolution manometry. J Am Coll Surg. 2009

5. Martínek J, Akiyama JI, Vackova Z, et al. Current treatment options for esophageal diseases. Ann N Y Acad Sci. 2016

6. Vaezi MF. Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2006

7. Hashmi S, Rao SS, Summers RW, Schulze K. Esophageal pressure topography, body position, and hiatal hernia. J Clin Gastroenterol. 2014

8. Malhotra A, Freston JW, Aziz K. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease. J Clin Gastroenterol. 2008

9. Zalvan CH, Hu S, Greenberg B, Geliebter J. A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux. JAMA Otolaryngol Head Neck Surg. 2017

10. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009

11. Kellerman R, Kintanar T. Gastroesophageal reflux disease. Prim Care. 2017

12. Ratcliffe EG, Jankowski JA. Gastroesophageal reflux disease and Barrett’s oesophagus: an overview of evidence-based guidelines. Pol Arch Intern Med. 2019

13. Rodriguez-Castro KI, Franceschi M, Miraglia C, et al. Autoimmune diseases in autoimmune atrophic gastritis. Acta Biomed. 2018

14. Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol. 2012

15. Rodriguez-Castro KI, Franceschi M, Noto A, et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018

16. Zhang Y, Weck MN, Schottker B, et al. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013

17. Early DS, Lightdale JR, Vargo JJ 2nd, et al, for the ASGE Standards of Practice Committee. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018

18. Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017

19. Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015

20. Genta RM. Differential diagnosis of reactive gastropathy. Semin Diagn Pathol. 2005

21. Aldoori WH, Giovannucci EL, Stampfer MJ, Rimm EB, Wing AL, Willett WC. A prospective study of alcohol, smoking, caffeine, and the risk of duodenal ulcer in men. Epidemiology. 1997

22. Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008

23. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017

24. Azhari H, Underwood F, King J, et al. The global incidence of peptic ulcer disease and its complications at the turn of the 21st century: a systematic review. J Can Assoc Gastroenterol. 2018

25. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010

26. Lanza FL, Chan FK, Quigley EM, for the Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009

27. Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017

28. Huffman JL, Schenker S. Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol. 2010

29. Donovan JM. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am. 1999

30. Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet. 1990

31. Rubens DJ. Hepatobiliary imaging and its pitfalls. Radiol Clin North Am. 2004